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Objective. To describe how virtual patients are being used to simulate real-life clinical scenarios in
undergraduate pharmacy education in Europe.
Methods. One hundred ninety-four participants at the 2011 Congress of the European Pharmaceutical
Students Association (EPSA) completed an exploratory cross-sectional survey instrument.
Results. Of the 46 universities and 23 countries represented at the EPSA Congress, only 12 students
from 6 universities in 6 different countries reported having experience with virtual patient technology.
The students were satisfied with the virtual patient technology and considered it more useful as
a teaching and learning tool than an assessment tool. Respondents who had not used virtual patient
technology expressed support regarding its potential benefits in pharmacy education. French and Dutch
students were significantly less interested in virtual patient technology than were their counterparts
from other European countries.
Conclusion. The limited use of virtual patients in pharmacy education in Europe suggests the need for
initiatives to increase the use of virtual patient technology and the benefits of computer-assisted
learning in pharmacy education.
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INTRODUCTION
Healthcare education, including pharmacy practice,
has benefited from simulation-based learning since the
early 1970s.1,2 Several types of simulation have been used
in pharmacy education in the United States, including
simulated and/or standardized patients, computer-based
learning simulations, high-fidelity human simulators, and
virtual-reality patients.2Multimedia-based healthcare ed-
ucation, including the use of virtual patients, is considered
to be educationally effective and has been described fa-
vorably when compared with traditional instruction.3
There are varying proposals for how to define virtual
patients. For instance, in proposing a virtual patient typol-
ogy, Huwendiek and colleagues described it as “an inter-
active computer simulation of real-life clinical scenarios
for the purpose of healthcare and medical training, educa-
tion, and assessment.”4 Apart from a number of medical
specialties comprising, among others, training in life-
saving events,5 virtual patients have also been used in
other health professions, ranging from nursing6 and oc-
cupational therapy7 to pharmacy practice.8,9 Pharmacists
have participated in initiatives to test virtual patient-based
education within multi-professional groups,10 as well as
in initiatives to develop interprofessional integration
among health professions students.11
Among other purposes, virtual patient technology
was designed to promote students’ clinical reasoning12
and the development of communication skills.13 Users’
opinions of this educational resource, including medical
students’ acceptance of virtual patient design principles
and of virtual patient-based learning and assessment tools,
indicate that virtual patient technology benefits both clin-
ical reasoning and communication skills.14-16
In addition to virtual laboratories for training stu-
dents in the basic sciences,17 multimedia simulation18,19
and virtual patient technology20 have been successfully
implemented in pharmacy education. While there have
been European virtual patient technology initiatives since
the early 2000s,21,22 in particular the development of
shared electronic patients (eViPs) across European coun-
tries,23 use amongEuropean colleges and schools of phar-
macy is not widespread and European users’ opinions of
this computer-assisted educational resource are not well
known.
The objective of this study was to explore the
perceptions and attitudes of European undergraduate
pharmacy students regarding the use or potential use
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of virtual patient technology during their pharmacy
education, and to use these findings as a starting point
for a more comprehensive survey of pharmacy educa-
tion programs and students in those programs.
METHODS
The research followed a descriptive, observational
cross-sectional design that used a printed self-administered
survey instrument to gather data. The aim was not to
obtain a statistical representation of users’ of virtual pa-
tient technology in the European pharmacy student pop-
ulation, but to create a first portray of how this technology
is being used.
Following ethical approval by the University of
Lisbon’sFacultyofPharmacy’s ethics committee,European
Pharmaceutical Students’ Association’s (EPSA’s) exec-
utive board gave its informed consent to conduct the sur-
vey. EPSA encompasses 28 European pharmacy student
associations as well as individual members. The study
was introduced and survey instrument administered dur-
ing a plenary session of EPSA’s 34th Annual Congress in
April 2011, in Lisbon. After being informed about the
study’s purpose and implications, participants voluntarily
completed the questionnaire. The data from this conve-
nience sample were collected anonymously and handled
confidentially. In a culturally diverse group that encom-
passed different countries and universities, researchers
were aware that differences might exist in study partici-
pants’ concepts of virtual reality and virtual patient tech-
nology. Thus, to avoid any associated bias, the survey
instrument followed the virtual patient technology model
definition proposed by Keele University,9 which defines
virtual patient technology as “an interactive learning sys-
tem that creates a computer-simulated environment of
patient real-life scenarios.” This definition was included
in the survey preamble. In order to contextualize the scope
of the survey instrument further, the preamble contained
the following additional information: “Interaction with
virtual patients occurs in a simulated reality created by
computer software, with animated images and sounds,
where the student talks and listens to the patient, as well
as dealing with patient’s emotions.”
Following the preamble, there were 3 main sections
to the questionnaire. The first was directed at participants
who had experience in computer-based interaction with
virtual patients. The secondwas designed for respondents
who had not yet used virtual patient technology but con-
sidered themselves potential virtual patient technology
users because they had experience using other forms
of computer-assisted education, such as Web-based
learning, digital network collaboration, or other audio/
video-based media. Apart from factual data-gathering,
these 2 sections also comprised a set of sentences, related
to respondents’ virtual patient technology use or potential
use (7 and 4 items, respectively), and the perceived impact
these had or would have in the learning process. These
items were rated on a 5-point Likert scale, ranging from
“strongly disagree” to “strongly agree.” Survey items
were developed based on findings from a literature re-
view25,26 and were intended to assess participants’ atti-
tudes, without any psychometric aims. The third section
solicited participants’ demographics, including their com-
puter proficiency, which students rated on a 7-point Likert
scale. Descriptive statistics as well as some inferential
analyses were performed, with a significance level set at
p,0.05 for all tests.
RESULTS
There were 304 registered participants in the EPSA
congress representing 72 universities in 26 different
European countries. Themajority (68.3%) were female;
fourth- and fifth-year students were the most widely rep-
resented, comprising 50.8% of all registered participants
(including internship students).
One hundred ninety-four respondents from46 differ-
ent universities completed a survey instrument, resulting
in a 63.8% participation rate. Responses were deemed
valid if respondents either claimed to have or not have ex-
perience with virtual patient technology in their pharmacy
education. There were missing responses from congress
participants representing the Czech Republic, Hungary,
and Serbia. Approximately 70% of the student respon-
dents were female and 90.0% were between 19 and 23
years of age. Although 26 different nationalities were
represented, all but 1 student (an Iraqi) were European.
There were no significant differences in age, gender,
and country and university of origin between the res-
pondents and all registered congress participants
(p.0.05). Table 1 presents students’ origin by country
and university.
Of 194 European pharmacy students, only 12 (6.2%)
had experience with virtual patient technology (desig-
nated in Table 1 with an asterisk), while 182 respondents
(93.8%) reported no experience with this technology.
In the virtual patient users’ group, 3 respondents had ex-
perienced patient simulation that used 3-dimensional
images and sound, whereas 9 described using other
forms of electronic patient simulation, such as animated
2-dimensional images, with or without sound. Eight stu-
dents had used virtual patient technology that involved
selecting from multiple-choice items and text boxes or
hearing audible responses from the virtual patient. For 3
respondents who had used virtual-reality systems, the
experience included listening to and speakingwith virtual
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Bulgaria Medical University of Sofia, Bulgaria 2 (1.1)
Croatia University of Pharmacy and Biochemistry, Croatia 5 (2.7)
Denmark University of Copenhagen,* Denmark 5 (2.7)
Finland University of Helsinki, Finland 4 (2.1)
University of Eastern Finland, Finland 1 (0.5)
France University of Rennes, France 1 (0.5)
University of Grenoble, France 1 (0.5)
University of Reims, France 1 (0.5)
Germany Ruprecht-Karls University of Heidelberg, Germany 1 (0.5)
University of Freiburg, Germany 2 (1.1)
University of Bonn, Germany 1 (0.5)
Greece University of Patras, Greece 4 (2.1)
Italy University of Genoa, Italy 2 (1.1)
University of Catania, Italy 1 (0.5)
Latvia University of Latvia, Latvia 3 (1.6)
Lithuania Lithuanian University of Health Sciences, Lithuania 3 (1.6)
Macedonia Ss. Cyril and Methodius University of Skopje, Macedonia 3 (1.6)
Malta University of Malta, Malta 1 (0.5)
Norway University of Bergen,* Norway 6 (3.2)
University of Oslo, Norway 3 (1.5)
University of Tromsø, Norway 5 (2.7)
Poland Medical University of Warsaw, Poland 5 (2.7)
Portugal University of Coimbra,* Portugal 9 (4.8)
University of Lisbon, Portugal 21 (11.2)
University of Porto, Portugal 7 (3.7)
Institute of Health Sciences Egas Moniz, Portugal 1 (0.5)
Romania Carol Davila University of Medicine and Pharmacy, Romania 17 (9.1)
Iuliu Hatieganu University of Medicine and Pharmacy, Romania 1 (0.5)
Victor Babes University of Medicine and Pharmacy, Romania 1 (0.5)
University of Cluj-Napoca,* Romania 1 (0.5)
Slovenia University of Ljubljana, Slovenia 17 (9.1)
Spain University of Santiago de Compostela, Spain 2 (1.1)
University of Alcala´ de Henares, Spain 1 (0.5)
Sweden Uppsala University, Sweden 9 (4.8)
University of Gothenburg,* Sweden 2 (1.1)
Switzerland ETH Zurich, Switzerland 2 (1.1)
University of Basel, Switzerland 3 (1.6)
The Netherlands University of Utrecht, The Netherlands 3 (1.6)
University of Groningen, The Netherlands 1 (0.5)
Turkey Ege University, Turkey 1 (0.5)
Hacettepe University, Turkey 10 ( 5.3)
Anadolu University, Turkey 4 (2.1)
Marmara University, Turkey 6 (3.2)
Istanbul University, Turkey 5 (2.7)
United Kingdom University of Portsmouth, United Kingdom 1 (0.5)
University of Aston,* United Kingdom 2 (1.1)
Missing origin 7 (–)
Total 194 (100.0)
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patients that had speech and voice recognition capabil-
ities. Six students reported having experienced virtual
patients within the context of a single subject or course,
such as pharmacy practice or pharmacotherapy. The
course(s) involving virtual patients were offered during
1 semester between years 2 and 4 of the students’ phar-
macy education program. The other 6 students had used
virtual patient technology more extensively, including
but not limited to independent/individual study, work
groups, case studies, as a lecture aid, in practical teach-
ing, and as a supplementary resource. It was not possible
to confirm length and depth of use (ie, beyond a semester
or in multiple subjects).
Of the teaching/learning methods that are associated
with use of virtual patient technology, the most common
(n59) occurred through a combination of work group and
case study. Virtual patients were used mostly during les-
sons (n58) and in lessonpreparation (n53), and to a lesser
extent in lesson follow-up, examinations, or other forms
of summative assessment (n51). Only 2 students were
aware of the point in timewhen virtual patient technology
was implemented asmandatory to complete the pharmacy
degree (before 2005). In most cases (n55), virtual patient
software was developed by their university or shared by
another academic institution, but commercial solutions
were also purchased (n57).
When asked about their computer proficiency, the
mean response of the subgroup of virtual patient technol-
ogy users was 6.26 0.9 on a 7-point scale on which 75
excellent. The perceptions about virtual patient technol-
ogy held by students who claimed to have experience
using and mastery of Internet technology are displayed
in Table 2. In this small, non-representative sample, the
mean values of all items were on the positive side of
the Likert scale; however, some respondents did express
negative opinions (disagreed or strongly disagreed) about
the following items: virtual patient technology gave me
an insightful learning experience, (8.3%); learning with
virtual patients was important to performing well on the
final examination (16.7%); easy access to virtual patients
at my convenience (25.0%); and a combination of virtual
patients and teaching events enhanced clinical reasoning
skills (9.1%). Bivariate nonparametric Spearman correla-
tions were computed, showing a strong positive correla-
tion between “virtual patient content and corresponding
teaching events complemented each other well” and “vir-
tual patients gave me an insightful learning experience,
which I wouldn’t have had from corresponding teaching
events alone.” (rho50.74; p50.006). A negative correla-
tion was found between “virtual patient content and cor-
responding teaching events complemented each other
well” and “combination of virtual patient technology
and corresponding teaching events made me feel better
prepared to care for a real life patient” (rho5-0.67;
p50.025).
Of the 182 respondents who described themselves as
not having experienced virtual patient technology, 72.9%
had used e-learning resources in their curriculum, 52
(29.1%) of whom indicated they had used blended-
learning resources. There was no significant difference
between the use of synchronous (52.9%) and asynchro-
nous (47.1%) systems. When questioned about the need
for virtual patient technology in their curriculum, 83.5%
agreed they should be used. Of these, 68.1% asserted that
the greatest need for virtual patient technology is in
teaching and to a lesser extent in assessment (15.4%)
but that virtual patients are especially useful in practical
individual learning (73.8%). Students’ self-assessed their
computer proficiency as 5.06 1.3 on a 7-point scale. This
value was lower than the mean for the students who
reported virtual patient technology use (p50.003). Table 3
presents the perceptions of non-virtual patient technology
Table 2. Perceptions Regarding Educational Use of Virtual Patients Among European Pharmacy Students With Virtual Patient
Experience (N512)
Survey Item Mean (SD)a
VP-related content and correspondent teaching events complemented each other well 4.3 (0.7)
VPs gave me an insightful learning experience, which I wouldn’t have had from corresponding
teaching events alone.
3.9 (0.9)
Learning with VPs is important in order to do well in the final examination for the course 3.7 (0.9)
Easy access to VPs at my convenience 3.4 (1.3)
Combination of VPs and corresponding teaching events enhanced my clinical reasoning skills.b 3.9 (1.0)
Combination of VPs and corresponding teaching events made me feel better prepared to care for
a real life patient.b
4.3 (0.8)
Overall, the combination of VPs and corresponding teaching events was a worthwhile learning experience.b 4.6 (0.7)
Abbreviations: VP5virtual patient.
a 5-point Likert scale on which15strongly disagree and 55strongly agree.
b Not all respondents answered this item.
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users regarding the potential use of electronic-assisted
learning and virtual patients.
All mean values were on the positive side of the
Likert scales for pharmacy students who claimed they
had no experience using virtual patient technology. The
strongest expression of confidence in virtual patient tech-
nology use was in relation to items regarding positive
beliefs in e-learning (56% agreed), and virtual patient
technology being a good asset for learning and education.
The most negative opinion was regarding professionals’
interaction with patients, which was the only item on
which there was a significant difference between male
and female respondents (p50.037): female respondents
showedmore confidence in the use of virtual patient tech-
nology to improve their communication skills. There
were no significant differences in responses based on
age, although ANOVA found differences in responses
among universities for 2 items, professionals’ interaction
with patients and the overall value of virtual patients as
a resource (p,0.001 and p50.001, respectively). How-
ever, because of low representation per country, it was not
possible to perform post-hoc testing.
Polish and Spanish pharmacy students had positive
perceptions of virtual patient technology use, whereas
confidence in this technology was more circumspect for
the French andDutch in particular, aswell as for the Swiss
and the Danes. Students from these last 4 countries dis-
agreed that using virtual technologywould help to improve
their communication skills. The only strong significant
correlation was between items 2c and 2d, belief in the
ability of virtual technology use to improve communica-
tions skills and belief that virtual technology would be an
asset to their educational process (p,0.001).
DISCUSSION
Simulation-based medical education has been used
since the 1970s and has covered many different objec-
tives, including student feedback on instructor training
aswell as skill acquisition andmaintenance as an outcome
measurement.26 The first decade of the 21st century has
seen many developments in computer-assisted instruc-
tion, ranging from applications on the World Wide
Web27 to dynamic interactions, provider and patient bi-
directional communication, often described as virtual
patients.28,29
Virtual patient technology in pharmacy education
has been available at only a few institutions since the
mid-2000s, with their usage in Europe being uncommon.
The existence of somewhat sophisticated clinical cases,
presented through computer programs and providing
access to shared IT platforms, would suggest greater use
of virtual patient technology. However, advanced dedi-
cated-software solutions, designed to mimic real patient
interactions as closely as possible in a virtual scenario,
making use of 3-dimensional images and sound, still do
not appear to be common in European pharmacy educa-
tion today. It seems that most European universities have
not invested in IT solutions for this purpose, despite con-
temporary society’s dependence on computers for a vast
array of activities, ranging from simple interpersonal
communication to social networking. Although IT is
widely accessible and actual virtual patient technology
initiatives in healthcare education exist, its low imple-
mentation in pharmacy education within a European ma-
trix of culturally and economically diverse countries is
somehow intriguing.
To augment implementation, the development of
virtual patient scenarios applicable to all health care pro-
fessions and resource sharing among professions and
institutions has been encouraged.30 One example of
cooperation in this area is the European eViP initiative
(http://www.virtualpatients.eu/), which works with inter-
active computer simulation of real-life clinical scenarios
formedical training, education, or assessment. This project
(now closed), co-funded by the European Commission,
was designed to be culturally adaptable and to address
other healthcare professions. Although endorsing the im-
portance of virtual patient technology as an educational
tool for future pharmacists, there has been little or no
transposition of eViP to European pharmacy education.
Table 3. Perceptions Regarding Educational Use of Virtual Patient Technology Among European Pharmacy Students With No
Virtual Patient Experience (N5182)
Survey Item
Respondents,
No. (%)a Mean (SD)b
I believe computers are indispensable tools for my learning process. 173 (95.1) 4.1 (1.2)
I believe e-learning platforms are helpful to improve my learning skills. 175 (96.2) 4.0 (1.1)
I believe using VPs would help me to improve my communication skills. 173 (95.1) 3.8 (1.1)
Overall, I think VPs would be a good asset to my educational process. 174 (95.6) 3.9 (1.0)
Abbreviations: VPs5virtual patients.
a Not all respondents answered all items.
b 5-point Likert scale on which 15strongly disagree and 55strongly agree.
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This deficit may be primarily related to the medical focus
of the project but also indicates, to some extent, the need
for pharmacy-related influence and involvement in ad-
vanced educational projects.
Despite the scarcity of virtual patient technology
use in European pharmacy education, the undergraduates
who reported using virtual patients were reasonably sat-
isfied with their experience. The most unfortunate aspect
was the lack of easy access to virtual patient technology,
which suggests that the systems in use may not be simple
computer software or Web-based applications, but rather
may involve sophisticated electronic equipment associ-
ated with the production of realistic virtual scenarios. On
the other hand, the use of virtual patient technology in con-
ducting examination was considered less effective, suggest-
ing that virtual technology may still be viewed by some as
experimental and not reliable as an assessment tool.
Based on their responses, even if students believed
that electronic patient simulation had a positive impact on
learning, they were not as confident that knowledge and
skills gained through use of virtual patient technology
would be helpful/advantageous in a real-life situation.
This is an interesting observation, as simulation is a well-
established training method in medical science and even
mandatory in professions such as aviation. Students
expressed doubts as to the actual capacity of virtual pa-
tient technology to accurately portray real-life situations
in a comprehensive way. Therefore, while suggesting that
virtual patient technology offers an imperfect approach to
reality, users of this resource discredit the potential training
benefits or are unhappy with the degree of authenticity.
The vast majority of pharmacy graduate respondents
who had not had experience with virtual patient technol-
ogy believed it to be advantageous as a supplementary
knowledge tool or in skill development, but, again, not
necessarily as a method for assessing that expertise or
skill. This disparity between the usefulness of virtual pa-
tient technology in learning and assessment denotes a lack
of confidence in virtual patient applications as a sound
method for establishing a course or examination grade.
However, methods for using virtual patient programs as
assessment tools in medical and nurse education may
differ from those used in pharmacy.31,32
Computer-assisted learning, including virtual pa-
tient technology, may be considered a privileged means
for developing important skills, such as interpersonal
communication.33 Virtual patient technology enables
universal access to specific standardized clinical situa-
tions, allowing for repeated practice, even if the quality
of the communication does not necessarily match that of
a simulated patient in terms of emotional content.34 In the
non-virtual patient technology user group, women were
more confident than men that virtual patients were bene-
ficial to the development of their interactive skills, which
might be related to women’s societal role as caregivers
and their perceived heightened sensitivity.35 Likewise,
students from different countries expressed doubts regard-
ing the benefits of virtual patient technology, although
the numbers from each country were low. French and
Dutch undergraduates were the most skeptical, which
prompted the examination of French andDutch pharmacy
education country profiles (PHARMINE project database
http://www.pharmine.org/). The system in France is de-
manding, with a highly selective traditional examination
at the end of the first year as well as the prompt introduc-
tion of professional experience in the form of a 6-week
traineeship in community pharmacy in the second year.
Meanwhile, in the Netherlands, pharmacy education is
heavily directed toward the pharmaceutical industry.
For example, 27% of the Dutch students’ learning is in
chemical sciences and only 3% in medical sciences dur-
ing the first 4 years of their curriculum. These 2 countries
illustrate 2 different bases that would account for a lower
appreciation of virtual patient technology: either there is
frequent contactwith real patients or the program’s focus is
on drug discovery and development. Additionally, apart
from a program’s structure and goals, other hurdles, such
as financial constraints, contribute to the weak implemen-
tation of an available technology. Future research using
different information sources is needed to confirm and ex-
pand on the findings from this study.
Study limitations include a convenience sampling
strategy, low rate of participation, and information bias.
Although this study was exploratory by nature, there is no
information on how congress participantsmight represent
the actual student population at large, and any compari-
sons between users and non-users subsamples should be
done with caution. On the other hand, the exact number of
congress participants may have been greater than 304,
primarily because of some unregistered Portuguese par-
ticipants representing universities with limited imple-
mentation of virtual patient technology.
Although the survey preamble and individual ques-
tions included an introductory text outlining the definition
of a virtual patient, not all respondents may have inter-
preted the concept in the same way, accounting for ran-
dom variations in replies that are impossible to quantify.
Therewere 3 countries (Latvia, Lithuania, andSweden) in
which participants might not have experienced virtual
patient technology, considering that none of those students
had reached the later stages of their degrees program (ie,
fifth or sixth year). Additionally, there were only a few
respondents from each country, which limits conclusions
about national differences.
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CONCLUSIONS
Virtual patient technology use in Europe is not as
common in pharmacy education as in medicine and nurs-
ing education. Although individual universities may have
developed or purchased virtual patient software, which in
both cases implies heightened consumption of financial and
other resources, a collective European initiative toward de-
velopingcommonpharmacyvirtual patient scenarioswould
be a first step to implementing this valuable resource in
pharmacy education. Such an initiative seems especially
relevant given the specificities of pharmacists’ work with
patients, in particular towhat concerns nonprescription drug
counseling and medication therapy management.
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